Search research articles
Contact Us
Filters
Showing results (41-50 of 112) with videos related to
Page
of 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2002
Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297
Jordan D Berlin, Paul Catalano, James P Thomas, et al.
Cancer Chemotherapy and Pharmacology
|
May 25, 2010
Two phase I studies of concurrent radiation therapy with continuous-infusion 5-fluorouracil plus epirubicin, and either cisplatin or irinotecan for locally advanced upper gastrointestinal adenocarcinomas
Weijing Sun, James M Metz, Maryann Gallagher, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 21, 2005
A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282
Steven J Cohen, Ralph Dobelbower, Stuart Lipsitz, et al.
Oncology
|
May 13, 2004
Phase II study of cisplatin and 5-fluorouracil (PF) and mitomycin C, vincristine, cisplatin and 5-fluorouracil (MVPF) in patients with metastatic large bowel cancer: an Eastern Cooperative Oncology Group study (EST 1285)
Kishan J Pandya, Myrto Lefkopoulou, Nicholas J Petrelli, et al.
Annals of Internal Medicine
|
February 19, 2002
Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089
Robert J Green, Joshua P Metlay, Kathleen Propert, et al.
Journal of the National Cancer Institute
|
August 8, 2002
Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer
A David McCollum, Paul J Catalano, Daniel G Haller, et al.
Gastrointestinal Cancer Research : GCR
|
March 6, 2009
Adjuvant Therapy for Stage II and III Colon Cancer: Consensus Report of the International Society of Gastrointestinal Oncology
John L Marshall, Daniel G Haller, Aimery de Gramont, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 30, 2008
Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297
David I Rosenthal, Paul J Catalano, Daniel G Haller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2003
Impact of diabetes mellitus on outcomes in patients with colon cancer
Jeffrey A Meyerhardt, Paul J Catalano, Daniel G Haller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 2005
Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089
Daniel G Haller, Paul J Catalano, John S Macdonald, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 112) with videos related to
Sort By:
Page
of 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2002
Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297
Jordan D Berlin, Paul Catalano, James P Thomas, et al.
Cancer Chemotherapy and Pharmacology
|
May 25, 2010
Two phase I studies of concurrent radiation therapy with continuous-infusion 5-fluorouracil plus epirubicin, and either cisplatin or irinotecan for locally advanced upper gastrointestinal adenocarcinomas
Weijing Sun, James M Metz, Maryann Gallagher, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 21, 2005
A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282
Steven J Cohen, Ralph Dobelbower, Stuart Lipsitz, et al.
Oncology
|
May 13, 2004
Phase II study of cisplatin and 5-fluorouracil (PF) and mitomycin C, vincristine, cisplatin and 5-fluorouracil (MVPF) in patients with metastatic large bowel cancer: an Eastern Cooperative Oncology Group study (EST 1285)
Kishan J Pandya, Myrto Lefkopoulou, Nicholas J Petrelli, et al.
Annals of Internal Medicine
|
February 19, 2002
Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089
Robert J Green, Joshua P Metlay, Kathleen Propert, et al.
Journal of the National Cancer Institute
|
August 8, 2002
Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer
A David McCollum, Paul J Catalano, Daniel G Haller, et al.
Gastrointestinal Cancer Research : GCR
|
March 6, 2009
Adjuvant Therapy for Stage II and III Colon Cancer: Consensus Report of the International Society of Gastrointestinal Oncology
John L Marshall, Daniel G Haller, Aimery de Gramont, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 30, 2008
Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297
David I Rosenthal, Paul J Catalano, Daniel G Haller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2003
Impact of diabetes mellitus on outcomes in patients with colon cancer
Jeffrey A Meyerhardt, Paul J Catalano, Daniel G Haller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 2005
Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089
Daniel G Haller, Paul J Catalano, John S Macdonald, et al.
Page
of 12